Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer Surgery

• Published in: Annals of surgical oncology Vol. 28; no. 7; pp. 3738 - 3748
• Main Authors: Kedrzycki, Martha S., Leiloglou, Maria, Ashrafian, Hutan, Jiwa, Natasha, Thiruchelvam, Paul T. R., Elson, Daniel S., Leff, Daniel R.
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.07.2021; Springer Nature B.V
• Subjects: Biopsy; Breast cancer; Breast Neoplasms - diagnostic imaging; Breast Neoplasms - surgery; Breast Oncology; Cancer surgery; Coloring Agents; Dyes; Female; Fluorescence; Humans; Hypersensitivity; Indocyanine Green; Lymph nodes; Lymphatic system; Medicine; Medicine & Public Health; Meta-analysis; Oncology; Optical Imaging; Radioisotopes; Sentinel Lymph Node - diagnostic imaging; Sentinel Lymph Node - surgery; Sentinel Lymph Node Biopsy; Surgery; Surgical mesh; Surgical Oncology
• ISSN: 1068-9265; 1534-4681; 1534-4681
• DOI: 10.1245/s10434-020-09288-7

Introduction Conventional methods for axillary sentinel lymph node biopsy (SLNB) are fraught with complications such as allergic reactions, skin tattooing, radiation, and limitations on infrastructure. A novel technique has been developed for lymphatic mapping utilizing fluorescence imaging. This meta-analysis aims to compare the gold standard blue dye and radioisotope (BD-RI) technique with fluorescence-guided SLNB using indocyanine green (ICG). Methods This study was registered with PROSPERO (CRD42019129224). The MEDLINE, EMBASE, Scopus, and Web of Science databases were searched using the Medical Subject Heading (MESH) terms ‘Surgery’ AND ‘Lymph node’ AND ‘Near infrared fluorescence’ AND ‘Indocyanine green’. Studies containing raw data on the sentinel node identification rate in breast cancer surgery were included. A heterogeneity test (using Cochran’s Q) determined the use of fixed- or random-effects models for pooled odds ratios (OR). Results Overall, 1748 studies were screened, of which 10 met the inclusion criteria for meta-analysis. ICG was equivalent to radioisotope (RI) at sentinel node identification (OR 2.58, 95% confidence interval [CI] 0.35–19.08, p  < 0.05) but superior to blue dye (BD) (OR 9.07, 95% CI 6.73–12.23, p  < 0.05). Furthermore, ICG was superior to the gold standard BD-RI technique (OR 4.22, 95% CI 2.17–8.20, p  < 0.001). Conclusion Fluorescence imaging for axillary sentinel node identification with ICG is equivalent to the single technique using RI, and superior to the dual technique (RI-BD) and single technique with BD. Hospitals using RI and/or BD could consider changing their practice to ICG given the comparable efficacy and improved safety profile, as well as the lesser burden on hospital infrastructure.